Komori
General Meetings of Shareholders4553TOWA PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Notice of Convocation of the 70th Annual General Meeting of Shareholders: Matters Omitted from the Documents Delivered

The business report, consolidated and non-consolidated financial statements, notes, audit reports and other documents attached to the notice of convocation of the 70th Annual General Meeting of Shareholders are omitted from the materials to be included in documents for shareholders who have requested delivery, and are provided through electronic provision measures.

Worth reading
9Immaterial
Scored from 2 of 4 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (70th fiscal year)
2026
Jun 24
Date and time(start time: Not disclosed)26 days from this disclosure to the meeting
Matters for resolution1 item
  1. Only the submission of a proposal for the appropriation of surplus dividends at the 70th Annual General Meeting of Shareholders scheduled to be held on 24 June 2026 is stated (agenda number and title: Not disclosed)

Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (70th fiscal year)
Date and time24 June 2026 (start time: Not disclosed)
Matters for resolutionOnly the submission of a proposal for the appropriation of surplus dividends at the 70th Annual General Meeting of Shareholders scheduled to be held on 24 June 2026 is stated (agenda number and title: Not disclosed)
Items this document does not state (3)
Shareholder ProposalDirector nomineePercentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The information is omitted from the documents to be delivered pursuant to applicable laws and regulations and Article 15, Paragraph 2 of the Company's Articles of Incorporation.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 70th Annual General Meeting of Shareholders: Matters Omitted from the Documents Delivered | TOWA PHARMACEUTICAL CO.,LTD. (4553) timely disclosure | Komori